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Abstract
Background Arteriovenous fistula (AVF) formation for long-
term haemodialysis in children is a niche discipline with little
data for guidance. We developed a dedicated Vascular Access
Clinic that is run jointly by a transplant surgeon, paediatric
nephrologist, dialysis nurse and a clinical vascular scientist
specialised in vascular sonography for the assessment and
surveillance of AVFs. We report the experience and 2-year
outcomes of this clinic.
Methods Twelve new AVFs were formed and 11 existing
AVFs were followed up for 2 years. All children were assessed
by clinical and ultrasound examination.
Results During the study period 12 brachiocephalic, nine
basilic vein transpositions and two radiocephalic AVFs were
followed up. The median age (interquartile range) and weight
of those children undergoing new AVF creation were 9.4 (in-
terquartile 3–17) years and 26.9 (14–67) kg, respectively. Pre-
operative ultrasound vascular mapping showed maximum
median vein and artery diameters of 3.0 (2–5) and 2.7 (2.0–
5.3) mm, respectively. Maturation scans 6 weeks after AVF
formation showed a median flow of 1277 (432–2880) ml/min.
Primary maturation rate was 83 % (10/12). Assisted matura-
tion was 100 %, with two patients requiring a single angio-
plasty. For the 11 children with an existing AVF the maximum
median vein diameter was 14.0 (8.0–26.0) mm, and the me-
dian flow rate was 1781 (800–2971) ml/min at a median of
153 weeks after AVF formation. Twenty-two AVFs were used
successfully for dialysis, a median kt/Vof 1.97 (1.8–2.9), and
urea reduction ratio of 80.7% (79.3–86%) was observed. One
child was transplanted before the AVF was used.
Conclusions Amultidisciplinary vascular clinic incorporating
ultrasound assessment is key to maintaining young children
on chronic haemodialysis via an AVF.
Keywords Arteriovenous fistulae . Children . Vascular
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Introduction
Adequate vascular access is a key factor for successful
haemodialysis (HD). The ideal vascular access, according to
the National Kidney Foundation–Dialysis Outcomes Quality
Initiative (NKF-DOQI) guidelines, should deliver an adequate
flow rate in combination with durability and a low rate of
complications [1]. An arteriovenous fistula (AVF) is generally
considered to be the optimum access for HD in adults and, as
suggested by an emerging body of evidence, also in children
[2–4]. However, most children continue to have a cuffed cen-
tral venous catheter (CVC) as the first choice for vascular
access [5, 6].
CVCs allow ease of insertion, immediate use and needle-
free dialysis, but they have several significant disadvantages,
namely, they are frequently associated with infection, throm-
bosis and stenosis that may cause obstruction of the central
vessels [2, 3, 6]. Although AVFs have a significant primary
failure rate (up to 40 % failure rate reported in the adult liter-
ature [7] and 25 % reported in a paediatric study [2]) and long
maturation time and require expert surgical skills, they are
associated with lower infection rates, fewer hospitalisations
and improved access longevity [2, 6, 8, 9]. In our centre, a
retrospective review of AVF outcomes in the 2-year period
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before the opening of a dedicated Vascular Access Clinic
showed that five of 25 (25 %) children had primary AVF
failure (successful revision possible in 2 of 3), and three had
secondary AVF failure (13.6 %) [2]. Learning from this expe-
rience and outcomes reported elsewhere [10–12], we set up a
multidisciplinary Access Clinic; the the outcomes are reported
here.
Published experience in the use of an AVF for long-term
HD in children is sparse, and direct comparisons should not be
drawn between the paediatric and adult populations [6, 7]. The
vascular biology of children is different to that of adults;
hence, the ideal vein and artery size, maturation times and
expected volume flow rates to achieve a functioning fistula
in children on HD are largely unknown [6]. In addition, fistula
function is not the only factor in successfully dialysing a child
on HD: a multidisciplinary approach involving the child, par-
ents, physicians, dialysis nurses, play specialists and psychol-
ogists is essential to achieving high quality long-term dialysis
[11].
In order to increase the use of AVFs in children on long-
term HD, we developed a dedicated Vascular Access Clinic,
run jointly by a transplant surgeon, paediatric nephrologist,
dialysis nurse and clinical vascular scientist specialised in vas-
cular sonography, to provide specialised care for the initiation
and monitoring of AVFs in children. Here, we report our 2-
year experience and outcomes.
Methods
We established a specialist Vascular Access Clinic at Great
Ormond Street Hospital, London in June 2013. Over the fol-
lowing 2 years, new AVFs were created in 12 children with
end-stage renal disease, and another 11 children with pre-
existing AVFs were followed up. This is a review of the pro-
spectively collected data. Details of the study population are
shown in Table 1.
All 21 children treated in the Vascular Access Clinic
during the 2-year study period were assessed clinically
and by ultrasound examination by a clinical vascular
scientist specilised in vascular sonography. Both exami-
nations are considered to be essential and are compli-
mentary but give different levels of detail regarding the
vascular biology for AVF planning.
Children are seen before a HD session in a warm,
child-friendly environment. With the child sitting up-
right, a clinical examination of both arms is performed.
The quality of the pulse at the elbow and wrist is
assessed by palpation—if there is a noticeable differ-
ence, then bilateral blood pressures are measured
followed by an arterial duplex assessment. A simple
tourniquet is applied just below the ante-cubital fossa
when assessing the forearm veins and around the
proximal humerus for assessment of the upper arm
veins. In some patients, venodilation is augmented by
eliciting a Lewis Response [13]—by firmly rubbing
the skin overlying the vein of interest venodilatation is
achieved. The relationship between the vein and artery
is crucial in terms of the incision and amount of mobi-
lization necessary to form the AVF. Drawing the posi-
tions of the vessels on the skin is a useful aid when the
surgical technique is discussed with the parent and
child. The chest is examined for evidence of distended
neck veins and superficial subcutaneous venous dilata-
tion indicative of central venous obstruction. If such an
obstruction is present, a bilateral central venogram with
intravenous contrast or magnetic resonance angiogram
(MRA) may be performed (regardless of the presence
of a CVC). However, we use a technique of non-
contrast MRA, also called time-of-flight or inflow angi-
ography, that utilizes phase differences to distinguish
blood from static tissue, thus avoiding contrast agents
and gadolinium.
The ultrasound assessment is performed in an adja-
cent room. Children are scanned in the supine position
in a warm, child-friendly environment. The veins in
both arms are mapped first without and the application
of a simple tourniquet and then with a tourniquet. The
arteries from the proximal brachial to the wrist are also
mapped. Maximum vein and arterial diameters are mea-
sured. A typical mapping diagram is shown in Fig. 1.
Since vein size can fluctuate depending on the room
temperature, tourniquet application and the Lewis re-
sponse, we always describe the maximum vein diameter
and select the largest vein for AVF formation in each
child, with a preference for distal (i.e. radial) over prox-
imal vessels when possible.
Children are evaluated approximately 6 weeks after
AVF formation to assess the maturation of the fistula
by ultrasound examination [maximum vessel diameter
(without tourniquet application) and volume flow are
recorded] and clinical examination. All children enter a
surveillance program consisting of volume flow assess-
ment (by ultrasound examination off dialysis), clinical
examination (including haemodynamic characteristics,
overlying skin condition, dilatation of central veins on
the chest wall, strength of distal pulses, symptoms of
steal) and a review of dialysis adequacy, at regular in-
tervals of 3–6 months.
The choice of AVF formed is dependent on a number of
factors, including vessel anatomy, previous access history,
hand dominance, intention for self cannulation and child/
parental choice (particularly relevant for girls concerned with
cosmesis). A single-stage cephalic-based AVF at the wrist or
elbow is the first choice fistula; when this is not possible a
brachiobasilic AVF is made in two stages.
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Fistulas are needled by the rope ladder or button-hole tech-
nique. New AVFs are first needled by the rope ladder tech-
nique, progressing to button-hole needling in patients who
self-needle or in whom a single carer consistently needles
the fistula.
Statistical analysis
Since most data were non-parametric, results are presented as
the median and interquartile range (IQR). Due to the small
number of patients only descriptive statistics were possible.
Results
Over a 2-year period we managed 23 patients in our clinic,
among whom 12were new patients (pre-AVF creation) and 11
had pre-existing AVFs. During these 2 years of practice the
percentage of children dialysing via a CVC decreased from 68
to 22 %.
Types of AV fistulas
All fistulas were formed in the upper limb: brachiocephalic
(n=12), basilic vein transposition (n=9) and radiocephalic
(n=2) fistulas. The median age and weight at AVF creation
were 9.4 (IQR 3–17) years and 26.9 (IQR 14–67) kg, respec-
tively. All children had started HD via a CVC; of these two
children (16 %) were late presenters and had required imme-
diate dialysis.
New AVF patients
Vessel selection and AVF flow rate
Details of the AVF site and number of stages in AVF forma-
tion are shown in Table 1. Ultrasound mapping of the vein
(with tourniquet) and artery used to create the AVFs showed a
maximum median diameter of 3.0 (IQR 2–5) and 2.7 (IQR 2–
5.3) mm, respectively.
At a median of 6 weeks after AVF formation, all children
were assessed for AVF maturation. The maximum median
vein (without tourniquet) and artery diameter was 8.6 (IQR
5.5–11) and 5.5 (IQR 4–8) mm, respectively. Themedian flow
through the AVF was 1277 (IQR 432–2880) ml/min.
AVF functional outcomes
Fistulas were needled at a median of 8 (IQR 5.1–62)
weeks after the final surgical procedure. Maturation is
defined by clinical examination in combination with ul-
trasound assessment applying the KDOQI ‘rule of 6’s’.
AVFs are first needled with size 17G needles, and de-
pending on the vessel size and as tolerated by the child,
the needles are increased to 14G or 15G. One child with
cardiomyopathy and a very low blood pressure had de-
layed fistula maturation, but was successfully needled at
Table 1 Demographics of the
patient cohort Patient characteristics New AVF
patients (n= 12)
Pre-existing AVF
patients (n = 11)
Age AVF formed (years) 9.2 (6.7–14.5) 9.6 (3.0–17.0)
Weight AVF formed (kg) 27.9 (20.6–45.8) 26.9 (14.0– 62.9)
Gender (males) 8 (66.7) 5 (45.5)
Underlying renal disease
Congenital anomalies of the kidneys
and urinary tract (CAKUT)
9 (75) 9 (82)
Cystic kidney disease 2 (16.6) –
Glomerulopathies 1 (8.3) 2 (18)
Access site
Brachiocephalic 5 (41.7) 7 (63.6)
Radiocephalic 2 (16.6) –
Basilic vein transposition 5 (41.7) 4 (36.7)
Stages operation
One stage 7 (60) 7 (63.6)
Two stage 5 (40) 4 (36.7)
Angioplasty 2 (16.6) 0 (-)
Data are presented as the median with the interquartile range (IQR) in parenthesis, or as a number with the
percentage in parenthesis, as appropriate
AVF, Arteriovenous fistulae
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62 weeks without further intervention. In two children,
extensive psychosocial preparation was required, thereby
delaying the time to first needling and highlighting the
importance of a multidisciplinary team with nursing and
psychosocial support as part of the Vascular Access
Clinic.
The primary maturation rate among our study population
was 81 % (9/11 AVFs; the patient with cardiomyopathy and
delayed maturation was excluded). The assisted maturation
rate was 100 %. Two children required angioplasty to achieve
maturation: both had brachiocephalic AVFs with post-
anastomotic stenosis and poor volume flow. A single
angioplasty was required in each case. One child received a
cadaveric renal transplant and never used the AVF created
although it was functionally mature based on the ultrasound
and clinical examinations.
Dialysis through a new AVF was started with a single nee-
dle (17G), using one lumen of the CVC simultaneously to
return the blood. Within 2 weeks dialysis with two needles
was achieved in ten of the 12 with new AVFs, and the CVC
was removed. The rope ladder technique was used initially for
needling the new AVR, with progression to the button-hole
technique when possible. Haematoma formation (‘blowing’)
using the AVF was seen in 30 % of children upon HD
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initiation via the AVF but managed conservatively by eleva-
tion, non-occlusive compression and re-assurance. There were
no cases where HD had to be terminated due to this problem.
At the 6-month follow-up (n=11), maximum median vein
diameter (without tourniquet) and artery diameter were 8.6
(IQR 5.8–27) and 6.0 (4.8–9.5) mm, respectively, with a me-
dian flow rate of 1441 (IQR 600–2880) ml/min At last review
after a median of 8.6 months post AVF formation (n=11), all
children had achieved excellent dialysis adequacy with a me-
dian urea reduction ratio (URR) of 80.7% (IQR 79–86%) and
Kt/Vof 1.97 (IQR 1.77–2.95).
Pre-existing AVF patients
Details of the AVF site and number of stages in AVF forma-
tion are shown in Table 1.
AVF functional outcomes
Four children received a kidney transplant during the study
period; all had functional AVFs with good flow rates and no
evidence of clinically significant stenosis. The 1-year primary
patency was 100 %. At a median of 179 weeks after fistula
formation, the median flow rate was 1556 (IQR 700–2600)
ml/min. The maximum median fistula vein diameter was 13.5
(IQR 8–27) mm and median artery diameter was 6.0 (IQR
4.8–11) mm. The median URR was 82 % (76–87 %) and
Kt/V was 2.2 (1.6–2.98).
Access complications
Four significant complications were seen in those using AVFs:
(1) an episode of thrombophlebitis in the collateral veins in a
basilic vein AVF with proximal subclavian stenosis, managed
with elevation and analgesia; (2) minor limb hypertrophy in a
child with a left brachiocephalic AVF; (3) surgical
aneurysmectomy and inflow reduction by anastamotic revi-
sion and distilization in a high flow brachiocephalic AVF with
cephalic arch syndrome; (4) excision of a bleeding side branch
in a brachiocephalic AVF with venous hypertension. HD was
continued in all cases without the need for a CVC.
Discussion
Renal transplantation is the first choice for all children with
end stage renal disease (ESRD) requiring renal replacement
therapy.Where HD is chosen for chronic dialysis, the literature
shows that for most children this is performed via a CVC.
Although more complicated to initiate, an AVF should be con-
sidered as the optimal method for vascular access in the ab-
sence of imminent transplantation. Previous reports have sug-
gested that vein diameters of 1.5–2.5 mm are used to fashion
AVFs in children [3, 14], there are no data on optimal vessel
diameter and outcomes of AVF formation in children. It would
not be appropriate to extrapolate from adult studies since the
vessels of children, although smaller, are far less likely to be
affected by diabetes and long-standing renal disease that cause
medial calcification and vessel stiffness [15]. To the best of our
knowledge, this paper is the first to describe vessel diameter
and outcomes of AVF formation in children.
Culture change regarding AVF usage
Achieving a high rate of AVF usage in a paediatric HD unit
may require a ‘culture change’ amongst medical/nursing staff
and children/parents away from the perceived convenience of
a CVC [3, 6]. The establishment of dedicated Vascular Access
Clinics has been vital in providing a focal point for education,
assessment and on-going management of children on chronic
HD. To assess this centralized service, children and parents
often travel long distances, and it is therefore essential that a
‘one stop’ approach is honoured for convenience and to min-
imize disruption, especially when the patients are attending
school. Part of the ‘popularity’ of CVC access is the unfamil-
iarity with the assessment, formation, needling and on-going
management of AVFs in children. We have found that our
Vascular Access Clinic serves as a hub for parents to see and
discuss the benefits of an AVF with the access team and other
children, while medical students, nurses and medical staff are
able to observe children thriving from the good quality access
and dialysis they provide. In the small, centralized world of
paediatric HD, ideas spread and the culture is gradually chang-
ing. After 2 years of practice the percentage of children
dialysing at our Vascular Access Clinic via a CVC has de-
creased from 68 to 22 %.
Suitability for AVF formation
The creation of an AVF should be considered for any child
who (1) is likely to need HD and (2) has no prospect of an
early renal transplant. This approach encourages early refer-
rals to the Vascular Access Clinic where the education of the
child and parent can commence. Initial discussions centre
around the nature of an AVF (how it works, the operation
and advantages over a CVC), the importance of vein preser-
vation for now and future AVFs, and a review of other renal
replacement options, including peritoneal dialysis and trans-
plantation. Vascular imaging and patient examination take
place in adjacent rooms so that the results of the clinical ex-
amination and real-time ultrasound imaging can be correlated.
The child then meets with a dialysis specialist nurse and re-
ceives a DVD about undergoing HD via an AVF with further
information and a contact phone number. After the AVF is
created, the child is brought back to the clinic in 4 weeks to
assess AVF maturation, identify and manage any
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complications and plan for needling of the AVF. Psychosocial
support is arranged where required.
In young girls the position of an AVF is discussed at the
initial clinic visit. For cosmesis, we have found a
brachiocephalic AVF is often requested as it can be hidden
under a sleeve. Hence, a brachiocephalic AVF in the dominant
limb is commonly preferred to a basilic vein transposition in
the non-dominant limb, the latter involving a larger incision
and two-stage approach. The button-hole technique is advo-
cated for needling the mature fistula to avoid aneurysmal
dilatation.
AVF maturation
A review of the literature revealed that vessel selection varies
between centres [2, 4, 8–10, 16, 17], but the authors of these
studies scarcely commented on primary failure and assisted
maturation rates. We found that selecting veins with a maxi-
mal median diameter of 3 mm (with tourniquet application)
and arteries with a maximum median diameter of 2.7 mm
resulted in a primary maturation rate of 82 %. We would
emphasize that clinical assessment is equally important as
ultrasound findings in terms of selecting the appropriate vein.
The 19 % (2 cases) of AVFs that failed primary maturation
were rescued with a single balloon angioplasty for single post
anastomotic lesions.
Of the 12 children with new AVFs, 11 were successfully
cannulated for dialysis at a median of 8 weeks. The timing of
initial cannulation reflects a number of factors, including ap-
plication of the KDOQI ‘rule of 6’s’ [1, 3], availability of
experienced staff to initiate cannulation, patient choice and
clinical urgency. We tend to delay initiating dialysis until we
are confident that the child is psychologically ready and the
AVF is highly likely to function without complication. In dis-
tinction to adults, ‘prolonged maturation’ is a feature of the
AVF of pediatric patients and reflects the differing vascular
biology of this latter patient group. The vein size of the fistual
and AVF flow rates are reviewed at 6 weeks to assess maturity.
If the AVF is immature we will continue the ultrasound and
clinical assessments at 6-week intervals until the fistula size is
‘static’ (no change in 6 weeks) before considering whether
further intervention is necessary to achieve maturity. This ap-
proach does mean that the CVC may be retained for a longer
time, but with the anticipation of a compliant child and func-
tional AVF. Little data are available on angioplasty-assisted
maturation of paediatric AVF, and we are reluctant to inter-
vene until it is essential. Hand-ball squeeze exercises are pre-
scribed for the older child to aid maturation.
For a brachiobasilic AVF we favour a two-stage approach
as this allows the fistula vein to increase in diameter and
length while it remains in situ, before making the transposition
and superficialization. A clinically significant post-
anastamotic stenosis, if it develops, is easier to surgically
revise at the second stage when mobilizing the entire vein
for the first time. Evidence favouring this approach is not
substantiated in the literature, but is based almost entirely on
adult studies [18].
Volume flow
Surprisingly, the volume flow rates seen after AVF formation
in relatively small vessels is comparable to those in adults.
Paediatric vascular biology differs from that in adults [19,
20]; consequently, key features such as smaller but compliant
vessels, short duration of uraemia, prolonged maturation, ab-
sence of steal syndrome and intolerance of central catheters
are important considerations when dealing with the paediatric
population. Similar flows have been reported by other re-
search groups without complication [21].
We have observed that children’s vessels behave differently
at surgery compared to those of adults. Besides the obviously
smaller vessel size in children, paediatric vessels exhibit in-
tense vasospasm when handled during surgery, which is not
noted in adults. Paediatric vessels are also far less likely to be
affected by diabetes and long-standing renal disease that cause
medial calcification and vessel stiffness [15]. In addition, as
stated in the section AVF maturation, distinct from the situa-
tion in adults, prolonged maturation is a feature of the paedi-
atric AVF, possibly also due to the growth potential in
children.
Access complications
The four access complications which developed in our study
population were all managed without the need to implant a
CVC with its inherent problems. For those requiring surgical
revision, a ‘single needle’ technique was used for HD while
the post-operative swelling resolved.
CVC usage
All patients commenced their HD programme with a CVC.
This is far from the ideal situation—the literature on AVFs in
adults shows a significantly increased mortality when HD is
initiated with a CVC even if the patient is converted to an AVF
later [22]. The reasons for failure to commence HD with a
functional AVF relate to a late referral pattern, the need for
visits to the Vascular Access Clinic at 6-week intervals, limit-
ed availability of operating time and a need for immediate
dialysis in the ‘crash landers’. In the future, children who are
likely to need chronic haemodialysis (i.e. no living donor
identified for early transplantation and those for whom perito-
neal dialysis is not an option) will be seen at an earlier stage in
the course of their renal decline for education, vein preserva-
tion and access planning. The benefits of a multidisciplinary
vascular clinic in access planning has been shown by another
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group [23]. Other paediatric groups who extoll AVF usage
have also shown a reduction in CVC usage [24].
Transplantation and AVF
Transplantation is unquestionably the best long-term renal re-
placement therapy for children in terms of survival, quality of
life and cost. However, even following transplantation, we
take the view that the AVF should not be ligated as it is a
precious resource for the future if dialysis should become
necessary once more. Earlier work by our group showed that
39 % of transplanted children (particularly teenagers) will re-
turn to dialysis during their childhood [25]. In addition, suit-
ably trained staff can use the AVF for venesection, thereby
maintaining the venous reserve for future AVF formation.
Surveillance and monitoring
All AVFs are monitored by the patient and nursing staff
by clinical assessment before the start of a dialysis ses-
sion, and all patients are encouraged to seek early as-
sistance in the case of concerns. A programmed assess-
ment of volume flow occurs every 3–6 months in the
access clinic by off-dialysis ultrasound (children travel-
ling from further afield are seen every 6 months). A
25 % reduction from baseline flow is considered to be
significant and warrants further investigation. Other
units employ an ultrasound dilution technique, and this
technique has been shown to be more sensitive than
fistulograms for detecting haemodynamically significant
stenosis [21].
Long-term patency
We have seen 100 % primary patency over 3 years in the
prevalent AVFs which is a testimony to the quality of care of
the dialysis staff. These children are often the most difficult to
transplant and hence face a prolonged and uncertain period on
HD. The waiting time for first cadaveric transplant in the UK
is often more than 1 year for children and increasing.
Consideration for fistula formation should occur early in the
assessment of the child with ESRD.
In conclusion, we have shown that a multidisciplinary vas-
cular clinic incorporating ultrasound assessment is key to suc-
cessful AVF formation and outcomes in young children.
Acknowledgements This work was supported by the National Institute
for Health Research Biomedical Research Centre at Great Ormond Street
Hospital for Children NHS Foundation Trust and University College
London.
Compliance with ethical standards
Conflict of interest The authors declare no conflict of interest.
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted
use, distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a link
to the Creative Commons license, and indicate if changes were made.
References
1. National Kidney Foundation (2006) NKF KDOQI guidelines.
Clinical practice guidelines and clinical practice recommendations.
2006 updates. Haemodialysis adequacy, peritoneal dialysis and vas-
cular access. Am J Kidney Dis 48[1]:S1–S322. Available at: http://
www2.kidney.org/professionals/KDOQI/guideline_upHD_PD_
VA/
2. Ma A, Shroff R, Hothi D, LopezMM, Veligratli F, Calder F, Rees L
(2013) A comparison of arteriovenous fistulas and central venous
lines for long-term chronic haemodialysis. Pediatr Nephrol 28:321–
326
3. Manook M, Calder F (2013) Practical aspects of arteriovenous fis-
tula formation in the pediatric population. Pediatr Nephrol 28:885–
893
4. Merouani A, Lallier M, Paquet J, Gagnon J, Lapeyraque AL (2014)
Vascular access for chronic hemodialysis in children: arteriovenous
fistula or central venous catheter? Pediatr Nephrol 29:2395–2401
5. Hayes WN, Watson AR, Callaghan N, Wright E, Stefanidis CJ
(2012) Vascular access: choice and complications in European pae-
diatric haemodialysis units. Pediatr Nephrol 27:999–1004
6. Mak RH, Warady BA (2013) Dialysis: vascular access in children–
arteriovenous fistula or CVC? Nat Rev Nephrol 9:9–11
7. Tordoir J, Canaud B, Haage P, Konner K, Basci A, Fouque D,
Kooman J, Martin-Malo A, Pedrini L, Pizzarelli F, Tattersall J,
Vennegoor M, Wanner C, ter WP, Vanholder R (2007) EBPG on
vascular access. Nephrol Dial Transplant 22(2):ii88–117
8. Chand DH, Valentini RP (2008) International pediatric fistula first
initiative: a call to action. Am J Kidney Dis 51:1016–1024
9. Sheth RD, Brandt ML, Brewer ED, Nuchtern JG, Kale AS,
Goldstein SL (2002) Permanent hemodialysis vascular access sur-
vival in children and adolescents with end-stage renal disease.
Kidney Int 62:1864–1869
10. Bourquelot P, Gagnadoux MF (1997) Vascular access for hemodi-
alysis in children. Pediatr Nephrol 11:659–660
11. Chand DH, Bednarz D, EagletonM, Krajewski L (2009) Avascular
access team can increase AV fistula creation in pediatric ESRD
patients: a single center experience. Semin Dial 22:679–683
12. Chand DH, Geary D, Patel H, Greenbaum LA, Nailescu C, Brier
ME, Valentini RP (2015) Barriers, biases, and beliefs about arterio-
venous fistula placement in children: a survey of the International
Pediatric Fistula First Initiative (IPFFI) within the Midwest
Pediatric Nephrology Consortium (MWPNC). Hemodial Int 19:
100–107
13. Lewis T, Grant RT (1924) Vascular reactions of the skin to injury.
The liberation of a histamine-like substance in injured skin; the
underlying cause of factitious urticaria and of wheals produced by
burning: and observations upon the nervous control of certain skin
reactions. Heart 11:209–265
14. Bourquelot P, Raynaud F, Pirozzi N (2003) Microsurgery in chil-
dren for creation of arteriovenous fistulas in renal and non-renal
diseases. Ther Apher Dial 7:498–503
15. Shroff R, Long DA, Shanahan C (2013) Mechanistic insights into
vascular calcification in CKD. J Am Soc Nephrol 24:179–189
16. Gradman WS, Lerner G, Mentser M, Rodriguez H, Kamil ES
(2005) Experience with autogenous arteriovenous access for
Pediatr Nephrol
hemodialysis in children and adolescents. Ann Vasc Surg 19:
609–612
17. Wartman SM, Rosen D, Woo K, Gradman WS, Weaver FA, Rowe
V (2014) Outcomes with arteriovenous fistulas in a pediatric pop-
ulation. J Vasc Surg 60:170–174
18. Cooper J, Power AH, DeRose G, Forbes TL, Dubois L
(2015) Similar failure and patency rates when comparing
one- and two-stage basilic vein transposition. J Vasc Surg
61:809–816
19. Casey ET, Murad MH, Rizvi AZ, Sidawy AN, McGrath
MM, Elamin MB, Flynn DN, McCausland FR, Vo DH, El-
Zoghby Z, Duncan AA, Tracz MJ, Erwin PJ, Montori VM
(2008) Surveillance of arteriovenous hemodialysis access: a
systematic review and meta-analysis. J Vasc Surg 48:48S–
54S
20. Hunter ID, Calder FR, Quan G, Chemla ES (2004) Vascular steal
syndrome occurring 20 years after surgical arteriovenous fistula
formation: an unusual cause of loss of hand function. Br J Plast
Surg 57:593–594
21. Ashoor IF, Hughson EA, Somers MJ (2015) Arteriovenous access
monitoring with ultrasound dilution in a pediatric hemodialysis
unit. Blood Purif 39:93–98
22. Astor BC, Eustace JA, Powe NR, Klag MJ, Fink NE, Coresh J
(2005) Type of vascular access and survival among incident hemo-
dialysis patients: the choices for healthy outcomes in caring for
ESRD (CHOICE) study. J Am Soc Nephrol 16:1449–1455
23. Menon S, Valentini RP, Kapur G, Layfield S, Mattoo TK (2009)
Effectiveness of a multidisciplinary clinic in managing children
with chronic kidney disease. Clin J Am Soc Nephrol 4:1170–1175
24. Matoussevitch V, Taylan C, Konner K, Gawenda M, Kuhr K,
Hoppe B, Brunkwall J (2015) AV fistula creation in paediatric
patients: outcome is independent of demographics and fistula type
reducing usage of venous catheters. J Vasc Access 16:382–387
25. Shroff R, Rees L, Trompeter R, Hutchinson C, Ledermann S (2006)
Long-term outcome of chronic dialysis in children. Pediatr Nephrol
21:257–264
Pediatr Nephrol
